12 Health Care Stocks Moving In Friday's Intraday Session
Portfolio Pulse from Benzinga Insights
In Friday's intraday session, several healthcare stocks experienced significant movements. Psyence Biomedical led the gainers with a 137.8% increase, while Amylyx Pharma saw the largest decline among the losers, dropping 81.5%. Other notable movers included Ainos, Mira Pharmaceuticals, and Joint, with substantial gains, and Immuron, Jin Medical International, and eFFECTOR Therapeutics among the losers.
March 08, 2024 | 5:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Amylyx Pharma's shares declined by 81.5%, with a market value of $238.2 million.
The dramatic decline in Amylyx Pharma's stock price could reflect negative news or investor sentiment, impacting its short-term market performance.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Ainos's stock increased by 91.96%, with a market cap of $10.0 million.
Ainos's significant stock price increase suggests positive market reception or company developments, likely influencing short-term investment interest.
CONFIDENCE 75
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Joint's stock rose 29.1% to $11.8, with a market value of $174.1 million, following Q4 earnings.
Joint's stock price increase following Q4 earnings suggests positive investor reaction to the company's financial performance, likely boosting short-term interest.
CONFIDENCE 85
IMPORTANCE 85
RELEVANCE 90
POSITIVE IMPACT
Mira Pharmaceuticals' shares increased by 34.75%, with a market cap of $18.9 million.
The increase in Mira Pharmaceuticals' stock price could indicate investor confidence and potential growth opportunities within the company.
CONFIDENCE 70
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Psyence Biomedical's stock surged 137.8%, with a market value of $40.4 million.
The substantial increase in Psyence Biomedical's stock price indicates strong investor interest, potentially due to positive developments within the company or its sector.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100